New abortifacient IUD Liletta approved by FDA

Posted on

Liletta (levonorgestrel) Intrauterine Device – formerly Levosert

Company: Medicines360 and Actavis plc
Date of Approval: February 27, 2015
Treatment for: Contraception [abortifacient mechanism of action, chemically and mechanically]

Liletta (levonorgestrel) is a hormonal intrauterine device (IUD) for use by women to prevent pregnancy for up to three years. The basic mechanism of action is abortifacient by action of the progestin levonorgestrel–which is poor at supressing ovulation–and the mechanical irritation of the endometrium after junior has been conceived and implanted in the womb.

Liletta FDA Approval History

One thought on “New abortifacient IUD Liletta approved by FDA

    eastsidehunky responded:
    April 9, 2015 at 11:59

    Reblogged this on EastSideHunky's Klobasa Klub and commented:

    Update 4/6/15: Liletta was entered into the market this week and one unit is showing an AWP=$750….keep that in mind when you pay your taxes and insurance premiums, covering this at no copay charge so women can chemically abort their children the next 3 years and possibly come down with a serious illness from the IUD, even unto death… ESH

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s